Bare-metal stents are a valid alternative to drug eluting stents, but are no longer considered to be state of the art.Load more
Bare-metal stents are a valid alternative to drug eluting stents, but are no longer considered to be state of the art.
One of the advantages of bare-metal stents is that these devices show vascular healing after 4–6 months with almost 100% re-endothelialisation. Late and very late stent thrombosis are rare events, seen only in patients with delayed healing or those whoa re allergic to nickel and chromium. Bare-metal stents are easy to implant, with a small profile and good trackability.
The major disadvantage of the bare-metal stent is that it is associated with restenosis rates from 15–20% and re-intervention will be required in 5–10% of cases. However, dual antiplatelet therapy is needed only for 1–2 months.Load Less
Rebecca L Noad, Colm G Hanratty, Simon J Walsh, et alInterventional Cardiology Review 2014;9(2):89-93DOI: https://doi.org/10.15420/articles/clinical-impact-stent-design
Nieves Gonzalo, Javier Escaned, Fernando Alfonso, et alRadcliffeCardiology.com, June 2014
Axel Schmermund, Holger EggebrechtInterventional Cardiology Review 2013;8(2):87-9DOI: https://doi.org/10.15420/icr.2013.8.2.87
Leif Thuesen, Niels Ramsing HolmInterventional Cardiology, 2012;7(1):49-52DOI: http://dx.doi.org/10.15420/icr.2012.7.1.49